-
1
-
-
34247623265
-
Coagulation abnormalities in critically ill patients
-
1750988 16879728 10.1186/cc4975
-
Levi M Opal SM Coagulation abnormalities in critically ill patients Crit Care 2006, 10:222. 1750988 16879728 10.1186/cc4975
-
(2006)
Crit Care
, vol.10
, pp. 222
-
-
Levi, M.1
Opal, S.M.2
-
2
-
-
0032895812
-
Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
-
10.1046/j.1523-1755.1999.00397.x 10201024
-
Cardigan RA McGloin H Mackie IJ Machin SJ Singer M Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration Kidney Int 1999, 55:1568-1574. 10.1046/j.1523-1755.1999.00397.x 10201024
-
(1999)
Kidney Int
, vol.55
, pp. 1568-1574
-
-
Cardigan, R.A.1
McGloin, H.2
Mackie, I.J.3
Machin, S.J.4
Singer, M.5
-
3
-
-
0031032533
-
Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways
-
10.1007/s001340050288 9037638
-
Salmon J Cardigan R Mackie I Cohen SL Machin S Singer M Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways Intensive Care Med 1997, 23:38-43. 10.1007/s001340050288 9037638
-
(1997)
Intensive Care Med
, vol.23
, pp. 38-43
-
-
Salmon, J.1
Cardigan, R.2
Mackie, I.3
Cohen, S.L.4
Machin, S.5
Singer, M.6
-
4
-
-
34447632044
-
The effects of continuous venovenous hemofiltration on coagulation activation
-
1751049 17069648 10.1186/cc5080
-
Bouman CS de Pont AC Meijers JC Bakhtiari K Roem D Zeerleder S Wolbink G Korevaar JC Levi M de Jonge E The effects of continuous venovenous hemofiltration on coagulation activation Crit Care 2006, 10:R150. 1751049 17069648 10.1186/cc5080
-
(2006)
Crit Care
, vol.10
-
-
Bouman, C.S.1
de Pont, A.C.2
Meijers, J.C.3
Bakhtiari, K.4
Roem, D.5
Zeerleder, S.6
Wolbink, G.7
Korevaar, J.C.8
Levi, M.9
de Jonge, E.10
-
5
-
-
11144283199
-
Blood flow reductions during continuous renal replacement therapy and circuit life
-
10.1007/s00134-004-2440-0 15448889
-
Baldwin I Bellomo R Koch B Blood flow reductions during continuous renal replacement therapy and circuit life Intensive Care Med 2004, 30:2074-2079. 10.1007/s00134-004-2440-0 15448889
-
(2004)
Intensive Care Med
, vol.30
, pp. 2074-2079
-
-
Baldwin, I.1
Bellomo, R.2
Koch, B.3
-
6
-
-
0030203864
-
Continuous renal replacement therapy in critically ill patients: Monitoring circuit function
-
8862637
-
Holt AW Bierer P Bersten AD Bury LK Vedig AE Continuous renal replacement therapy in critically ill patients: Monitoring circuit function Anaesth Intensive Care 1996, 24:423-429. 8862637
-
(1996)
Anaesth Intensive Care
, vol.24
, pp. 423-429
-
-
Holt, A.W.1
Bierer, P.2
Bersten, A.D.3
Bury, L.K.4
Vedig, A.E.5
-
7
-
-
0034100133
-
Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study
-
10.1097/00003246-200002000-00022 10708177
-
de Pont AC Oudemans-van Straaten HM Roozendaal KJ Zandstra DF Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study Crit Care Med 2000, 28:421-425. 10.1097/00003246-200002000-00022 10708177
-
(2000)
Crit Care Med
, vol.28
, pp. 421-425
-
-
de Pont, A.C.1
Oudemans-van Straaten, H.M.2
Roozendaal, K.J.3
Zandstra, D.F.4
-
8
-
-
0033647461
-
Transfusion requirements during continuous veno-venous haemofiltration: The importance of filter life
-
10.1007/s001340000676 11193279
-
Cutts MW Thomas AN Kishen R Transfusion requirements during continuous veno-venous haemofiltration: The importance of filter life Intensive Care Med 2000, 26:1694-1697. 10.1007/s001340000676 11193279
-
(2000)
Intensive Care Med
, vol.26
, pp. 1694-1697
-
-
Cutts, M.W.1
Thomas, A.N.2
Kishen, R.3
-
9
-
-
32844461837
-
Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based?
-
10.1007/s00134-005-0044-y 16453140
-
Oudemans-van Straaten HM Wester JP de Pont AC Schetz MR Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive Care Med 2006, 32:188-202. 10.1007/ s00134-005-0044-y 16453140
-
(2006)
Intensive Care Med
, vol.32
, pp. 188-202
-
-
Oudemans-van Straaten, H.M.1
Wester, J.P.2
de Pont, A.C.3
Schetz, M.R.4
-
10
-
-
33748087100
-
Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH - An in vitro study
-
10.1093/ndt/gfl068 16567341
-
Unger JK Haltern C Portz B Dohmen B Gressner A Rossaint R Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH - an in vitro study Nephrol Dial Transplant 2006, 21:2191-2201. 10.1093/ndt/gfl068 16567341
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 2191-2201
-
-
Unger, J.K.1
Haltern, C.2
Portz, B.3
Dohmen, B.4
Gressner, A.5
Rossaint, R.6
-
12
-
-
0030795624
-
Central venous catheters for haemodialysis: Looking for optimal blood flow
-
10.1093/ndt/12.8.1689 9269650
-
Jean G Chazot C Vanel T Charra B Terrat JC Calemard E Laurent G Central venous catheters for haemodialysis: Looking for optimal blood flow Nephrol Dial Transplant 1997, 12:1689-1691. 10.1093/ndt/12.8.1689 9269650
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 1689-1691
-
-
Jean, G.1
Chazot, C.2
Vanel, T.3
Charra, B.4
Terrat, J.C.5
Calemard, E.6
Laurent, G.7
-
13
-
-
33747022052
-
How to improve dialysis adequacy in patients with vascular access problems
-
16868897
-
Mandolfo S Borlandelli S Ravani P Imbasciati E How to improve dialysis adequacy in patients with vascular access problems J Vasc Access 2006, 7:53-59. 16868897
-
(2006)
J Vasc Access
, vol.7
, pp. 53-59
-
-
Mandolfo, S.1
Borlandelli, S.2
Ravani, P.3
Imbasciati, E.4
-
14
-
-
0344906173
-
Subclavian vascular access stenosis in dialysis patients: Natural history and risk factors
-
9697674
-
Hernández D Díaz F Rufino M Lorenzo V Pérez T Rodríguez A De Bonis E Losada M González-Posada JM Torres A Subclavian vascular access stenosis in dialysis patients: Natural history and risk factors J Am Soc Nephrol 1998, 9:1507-1510. 9697674
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 1507-1510
-
-
Hernández, D.1
Díaz, F.2
Rufino, M.3
Lorenzo, V.4
Pérez, T.5
Rodríguez, A.6
De Bonis, E.7
Losada, M.8
González-Posada, J.M.9
Torres, A.10
-
15
-
-
0029071360
-
Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis
-
7640421
-
Agraharkar M Isaacson S Mendelssohn D Muralidharan J Mustata S Zevallos G Besley M Uldall R Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis ASAIO J 1995, 41:169-172. 7640421
-
(1995)
ASAIO J
, vol.41
, pp. 169-172
-
-
Agraharkar, M.1
Isaacson, S.2
Mendelssohn, D.3
Muralidharan, J.4
Mustata, S.5
Zevallos, G.6
Besley, M.7
Uldall, R.8
-
16
-
-
0035522634
-
Acute dialysis catheters
-
10.1046/j.1525-139x.2001.00107.x 11851928
-
Oliver MJ Acute dialysis catheters Semin Dial 2001, 14:432-435. 10.1046/ j.1525-139x.2001.00107.x 11851928
-
(2001)
Semin Dial
, vol.14
, pp. 432-435
-
-
Oliver, M.J.1
-
17
-
-
34250867431
-
Real-time ultrasound-guided catheterisation of the internal jugular vein: A prospective comparison with the landmark technique in critical care patients
-
1794469 17112371 10.1186/cc5101
-
Karakitsos D Labropoulos N De Groot E Patrianakos AP Kouraklis G Poularas J Samonis G Tsoutsos DA Konstadoulakis MM Karabinis A Real-time ultrasound-guided catheterisation of the internal jugular vein: A prospective comparison with the landmark technique in critical care patients Crit Care 2006, 10:R162. 1794469 17112371 10.1186/cc5101
-
(2006)
Crit Care
, vol.10
-
-
Karakitsos, D.1
Labropoulos, N.2
De Groot, E.3
Patrianakos, A.P.4
Kouraklis, G.5
Poularas, J.6
Samonis, G.7
Tsoutsos, D.A.8
Konstadoulakis, M.M.9
Karabinis, A.10
-
18
-
-
30944443546
-
Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients
-
10.1681/ASN.2004100870 16033861
-
Weijmer MC van den Dorpel MA Van de Ven PJ ter Wee PM van Geelen JA Groeneveld JO van Jaarsveld BC Koopmans MG le Poole CY Schrander-Van der Meer AM et al. CITRATE Study Group Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients J Am Soc Nephrol 2005, 16:2769-2777. 10.1681/ ASN.2004100870 16033861
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2769-2777
-
-
Weijmer, M.C.1
van den Dorpel, M.A.2
Van de Ven, P.J.3
ter Wee, P.M.4
van Geelen, J.A.5
Groeneveld, J.O.6
van Jaarsveld, B.C.7
Koopmans, M.G.8
le Poole, C.Y.9
Schrander-Van der Meer, A.M.10
-
19
-
-
33846657539
-
Sodium citrate 4% locking solution for central venous dialysis catheters - An effective, more cost-efficient alternative to heparin
-
10.1093/ndt/gfl606 17065193
-
Grudzinski L Quinan P Kwok S Pierratos A Sodium citrate 4% locking solution for central venous dialysis catheters - an effective, more cost-efficient alternative to heparin Nephrol Dial Transplant 2007, 22:471-476. 10.1093/ndt/gfl606 17065193
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 471-476
-
-
Grudzinski, L.1
Quinan, P.2
Kwok, S.3
Pierratos, A.4
-
20
-
-
34248677596
-
Maintaining the CRRT circuit: Non-anticoagulant alternatives
-
10.1016/S1036-7314(06)80026-3 17165492
-
Davies H Leslie G Maintaining the CRRT circuit: Non-anticoagulant alternatives Aust Crit Care 2006, 19:133-138. 10.1016/ S1036-7314(06)80026-3 17165492
-
(2006)
Aust Crit Care
, vol.19
, pp. 133-138
-
-
Davies, H.1
Leslie, G.2
-
21
-
-
0035532679
-
Anticoagulation in continuous renal replacement therapy
-
11395897
-
Schetz M Anticoagulation in continuous renal replacement therapy Contrib Nephrol 2001, 132:283-303. 11395897
-
(2001)
Contrib Nephrol
, pp. 283-303
-
-
Schetz, M.1
-
22
-
-
0033984593
-
Factors affecting system clotting in continuous renal replacement therapy: Results of a randomized, controlled trial
-
10661483
-
Ramesh Prasad GV Palevsky PM Burr R Lesko JM Gupta B Greenberg A Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial Clin Nephrol 2000, 53:55-60. 10661483
-
(2000)
Clin Nephrol
, vol.53
, pp. 55-60
-
-
Ramesh Prasad, G.V.1
Palevsky, P.M.2
Burr, R.3
Lesko, J.M.4
Gupta, B.5
Greenberg, A.6
-
23
-
-
33845933055
-
Solute removal during continuous renal replacement therapy in critically ill patients: Convection versus diffusion
-
1550874 16646985 10.1186/cc4903
-
Ricci Z Ronco C Bachetoni A D'amico G Rossi S Alessandri E Rocco M Pietropaoli P Solute removal during continuous renal replacement therapy in critically ill patients: Convection versus diffusion Crit Care 2006, 10:R67. 1550874 16646985 10.1186/cc4903
-
(2006)
Crit Care
, vol.10
-
-
Ricci, Z.1
Ronco, C.2
Bachetoni, A.3
D'amico, G.4
Rossi, S.5
Alessandri, E.6
Rocco, M.7
Pietropaoli, P.8
-
24
-
-
26044442793
-
Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT)
-
10.1093/ndt/gfh817 15855212
-
Brophy PD Somers MJ Baum MA Symons JM McAfee N Fortenberry JD Rogers K Barnett J Blowey D Baker C et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT) Nephrol Dial Transplant 2005, 20:1416-1421. 10.1093/ndt/ gfh817 15855212
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 1416-1421
-
-
Brophy, P.D.1
Somers, M.J.2
Baum, M.A.3
Symons, J.M.4
McAfee, N.5
Fortenberry, J.D.6
Rogers, K.7
Barnett, J.8
Blowey, D.9
Baker, C.10
-
25
-
-
0346937718
-
Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control
-
10.1159/000072492 12972719
-
Uchino S Fealy N Baldwin I Morimatsu H Bellomo R Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control Nephron Clin Pract 2003, 94:c94-c98. 10.1159/000072492 12972719
-
(2003)
Nephron Clin Pract
, vol.94
-
-
Uchino, S.1
Fealy, N.2
Baldwin, I.3
Morimatsu, H.4
Bellomo, R.5
-
26
-
-
21044454215
-
Filter run time in CVVH: Pre-versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation
-
10.1159/000083938 15711037
-
Van der Voort PH Gerritsen RT Kuiper MA Egbers PH Kingma WP Boerma EC Filter run time in CVVH: Pre-versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation Blood Purif 2005, 23:175-180. 10.1159/000083938 15711037
-
(2005)
Blood Purif
, vol.23
, pp. 175-180
-
-
Van der Voort, P.H.1
Gerritsen, R.T.2
Kuiper, M.A.3
Egbers, P.H.4
Kingma, W.P.5
Boerma, E.C.6
-
27
-
-
0035651043
-
Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms
-
11792761
-
Clark WR Gao D Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms J Am Soc Nephrol 2002, 13(Suppl 1):S41-S47. 11792761
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.SUPPL. 1
-
-
Clark, W.R.1
Gao, D.2
-
28
-
-
30944437636
-
Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration
-
10.1111/j.1523-1755.2005.00694.x 16221237
-
Padrini R Canova C Conz P Mancini E Rizzioli E Santoro A Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration Kidney Int 2005, 68:2331-2337. 10.1111/ j.1523-1755.2005.00694.x 16221237
-
(2005)
Kidney Int
, vol.68
, pp. 2331-2337
-
-
Padrini, R.1
Canova, C.2
Conz, P.3
Mancini, E.4
Rizzioli, E.5
Santoro, A.6
-
29
-
-
34247525990
-
Improved protein-adsorption resistance of polyethersulfone membranes via surface segregation of ultrahigh molecular weight poly(styrene-alt-maleic anhydride)
-
10.1016/j.colsurfb.2007.01.021 17379486
-
Zhu LP Zhang XX Xu L Du CH Zhu BK Xu YY Improved protein-adsorption resistance of polyethersulfone membranes via surface segregation of ultrahigh molecular weight poly(styrene-alt-maleic anhydride) Colloids Surf B Biointerfaces 2007, 57:189-197. 10.1016/j.colsurfb.2007.01.021 17379486
-
(2007)
Colloids Surf B Biointerfaces
, vol.57
, pp. 189-197
-
-
Zhu, L.P.1
Zhang, X.X.2
Xu, L.3
Du, C.H.4
Zhu, B.K.5
Xu, Y.Y.6
-
30
-
-
0037317065
-
New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding
-
10.1093/ndt/18.2.252 12543877
-
Chanard J Lavaud S Randoux C Rieu P New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding Nephrol Dial Transplant 2003, 18:252-257. 10.1093/ndt/18.2.252 12543877
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 252-257
-
-
Chanard, J.1
Lavaud, S.2
Randoux, C.3
Rieu, P.4
-
32
-
-
0141618423
-
Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane
-
10.1093/ndt/gfg272 13679486
-
Lavaud S Canivet E Wuillai A Maheut H Randoux C Bonnet JM Renaux JL Chanard J Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane Nephrol Dial Transplant 2003, 18:2097-2104. 10.1093/ndt/gfg272 13679486
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2097-2104
-
-
Lavaud, S.1
Canivet, E.2
Wuillai, A.3
Maheut, H.4
Randoux, C.5
Bonnet, J.M.6
Renaux, J.L.7
Chanard, J.8
-
33
-
-
33745557818
-
In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique
-
16302224
-
Sperling C Houska M Brynda E Streller U Werner C In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique J Biomed Mater Res A 2006, 76:681-689. 16302224
-
(2006)
J Biomed Mater Res A
, vol.76
, pp. 681-689
-
-
Sperling, C.1
Houska, M.2
Brynda, E.3
Streller, U.4
Werner, C.5
-
34
-
-
0034865381
-
Renal replacement therapy: Physical properties of hollow fibers influence efficiency
-
11482501
-
Dungen HD von HC Ronco C Kox WJ Spies CD Renal replacement therapy: physical properties of hollow fibers influence efficiency Int J Artif Organs 2001, 24:357-366. 11482501
-
(2001)
Int J Artif Organs
, vol.24
, pp. 357-366
-
-
Dungen, H.D.1
von, H.C.2
Ronco, C.3
Kox, W.J.4
Spies, C.D.5
-
35
-
-
0027358699
-
Anticoagulant regimens in acute continuous hemodiafiltration: A comparative study
-
10.1007/BF01694706 8227722
-
Bellomo R Teede H Boyce N Anticoagulant regimens in acute continuous hemodiafiltration: A comparative study Intensive Care Med 1993, 19:329-332. 10.1007/BF01694706 8227722
-
(1993)
Intensive Care Med
, vol.19
, pp. 329-332
-
-
Bellomo, R.1
Teede, H.2
Boyce, N.3
-
36
-
-
0033653649
-
Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
-
10.1007/s001340000691 11193272
-
Tan HK Baldwin I Bellomo R Continuous veno-venous hemofiltration without anticoagulation in high-risk patients Intensive Care Med 2000, 26:1652-1657. 10.1007/s001340000691 11193272
-
(2000)
Intensive Care Med
, vol.26
, pp. 1652-1657
-
-
Tan, H.K.1
Baldwin, I.2
Bellomo, R.3
-
38
-
-
0347320808
-
Continuous venovenous hemofiltration without anticoagulation
-
10.1097/01.MAT.0000104822.30759.A7 14763495
-
Uchino S Fealy N Baldwin I Morimatsu H Bellomo R Continuous venovenous hemofiltration without anticoagulation ASAIO J 2004, 50:76-80. 10.1097/ 01.MAT.0000104822.30759.A7 14763495
-
(2004)
ASAIO J
, vol.50
, pp. 76-80
-
-
Uchino, S.1
Fealy, N.2
Baldwin, I.3
Morimatsu, H.4
Bellomo, R.5
-
39
-
-
0029449098
-
Antithrombin III deficiency during continuous venovenous hemodialysis
-
8529370
-
Bastien O French P Paulus S Filley S Berruyer M Dechavanne M Estanove S Antithrombin III deficiency during continuous venovenous hemodialysis Contrib Nephrol 1995, 116:154-158. 8529370
-
(1995)
Contrib Nephrol
, vol.116
, pp. 154-158
-
-
Bastien, O.1
French, P.2
Paulus, S.3
Filley, S.4
Berruyer, M.5
Dechavanne, M.6
Estanove, S.7
-
40
-
-
23044466767
-
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
-
10.1111/j.1523-1755.2005.00342.x 15882280
-
Kutsogiannis DJ Gibney RT Stollery D Gao J Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Kidney Int 2005, 67:2361-2367. 10.1111/ j.1523-1755.2005.00342.x 15882280
-
(2005)
Kidney Int
, vol.67
, pp. 2361-2367
-
-
Kutsogiannis, D.J.1
Gibney, R.T.2
Stollery, D.3
Gao, J.4
-
41
-
-
33750302263
-
Short filter life span during hemofiltration in sepsis: Antithrombine (AT) supplementation should be a good way to sort out this problem
-
10.1159/000083654
-
Joannes-Boyau O Laffargue M Honore P Gauche B Fleureau C Roze H Janvier G Short filter life span during hemofiltration in sepsis: Antithrombine (AT) supplementation should be a good way to sort out this problem Blood Purif 2005, 23:149-174. 10.1159/000083654
-
(2005)
Blood Purif
, vol.23
, pp. 149-174
-
-
Joannes-Boyau, O.1
Laffargue, M.2
Honore, P.3
Gauche, B.4
Fleureau, C.5
Roze, H.6
Janvier, G.7
-
42
-
-
34247638669
-
Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: A case-control study
-
1550897 16542495 10.1186/cc4853
-
du Cheyron D Bouchet B Bruel C Daubin C Ramakers M Charbonneau P Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: A case-control study Crit Care 2006, 10:R45. 1550897 16542495 10.1186/ cc4853
-
(2006)
Crit Care
, vol.10
-
-
du Cheyron, D.1
Bouchet, B.2
Bruel, C.3
Daubin, C.4
Ramakers, M.5
Charbonneau, P.6
-
43
-
-
0141819138
-
The protein C pathway
-
10.1378/chest.124.3_suppl.26S 12970121
-
Esmon CT The protein C pathway Chest 2003, 124:26S-32S. 10.1378/ chest.124.3_suppl.26S 12970121
-
(2003)
Chest
, vol.124
-
-
Esmon, C.T.1
-
44
-
-
0346817408
-
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis
-
10.1007/s00134-003-1781-4 12761613
-
de Pont AC Bouman CS de Jonge E Vroom MB Büller HR Levi M Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis Intensive Care Med 2003, 29:1205. 10.1007/ s00134-003-1781-4 12761613
-
(2003)
Intensive Care Med
, vol.29
, pp. 1205
-
-
de Pont, A.C.1
Bouman, C.S.2
de Jonge, E.3
Vroom, M.B.4
Büller, H.R.5
Levi, M.6
-
45
-
-
33644855939
-
Practice patterns in the management of acute renal failure in the critically ill patient: An international survey
-
10.1093/ndt/gfi296 16326743
-
Ricci Z Ronco C D'amico G De Felice R Rossi S Bolgan I Bonello M Zamperetti N Petras D Salvatori G Practice patterns in the management of acute renal failure in the critically ill patient: An international survey Nephrol Dial Transplant 2006, 21:690-696. 10.1093/ndt/gfi296 16326743
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 690-696
-
-
Ricci, Z.1
Ronco, C.2
D'amico, G.3
De Felice, R.4
Rossi, S.5
Bolgan, I.6
Bonello, M.7
Zamperetti, N.8
Petras, D.9
Salvatori, G.10
-
46
-
-
0037302947
-
The use of the activated clotting time for monitoring heparin therapy in critically ill patients
-
12594595
-
De Waele JJ Van Cauwenberghe S Hoste E Benoit D Colardyn F The use of the activated clotting time for monitoring heparin therapy in critically ill patients Intensive Care Med 2003, 29:325-328. 12594595
-
(2003)
Intensive Care Med
, vol.29
, pp. 325-328
-
-
De Waele, J.J.1
Van Cauwenberghe, S.2
Hoste, E.3
Benoit, D.4
Colardyn, F.5
-
47
-
-
4644308426
-
Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
10.1378/chest.126.3_suppl.188S 15383472
-
Hirsh J Raschke R Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126:188S-203S. 10.1378/chest.126.3_suppl.188S 15383472
-
(2004)
Chest
, vol.126
-
-
Hirsh, J.1
Raschke, R.2
-
48
-
-
0029035681
-
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
-
10.1056/NEJM199505183322003 7715641
-
Warkentin TE Levine MN Hirsh J Horsewood P Roberts RS Gent M Kelton JG Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 1995, 332:1330-1335. 10.1056/NEJM199505183322003 7715641
-
(1995)
N Engl J Med
, vol.332
, pp. 1330-1335
-
-
Warkentin, T.E.1
Levine, M.N.2
Hirsh, J.3
Horsewood, P.4
Roberts, R.S.5
Gent, M.6
Kelton, J.G.7
-
50
-
-
0033819828
-
Heparins and blood polymorphonuclear stimulation in haemodialysis: An expansion of the biocompatibility concept
-
10.1093/ndt/15.10.1631 11007833
-
Leitienne P Fouque D Rigal D Adeleine P Trzeciak MC Laville M Heparins and blood polymorphonuclear stimulation in haemodialysis: An expansion of the biocompatibility concept Nephrol Dial Transplant 2000, 15:1631-1637. 10.1093/ndt/15.10.1631 11007833
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 1631-1637
-
-
Leitienne, P.1
Fouque, D.2
Rigal, D.3
Adeleine, P.4
Trzeciak, M.C.5
Laville, M.6
-
51
-
-
0027168729
-
Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit
-
8215953
-
Jeffrey RF Khan AA Douglas JT Will EJ Davison AM Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit Artif Organs 1993, 17:717-720. 8215953
-
(1993)
Artif Organs
, vol.17
, pp. 717-720
-
-
Jeffrey, R.F.1
Khan, A.A.2
Douglas, J.T.3
Will, E.J.4
Davison, A.M.5
-
52
-
-
0032749006
-
A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration
-
10.1097/00003246-199910000-00026 10548211
-
Reeves JH Cumming AR Gallagher L O'Brien JL Santamaria JD A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration Crit Care Med 1999, 27:2224-2228. 10.1097/ 00003246-199910000-00026 10548211
-
(1999)
Crit Care Med
, vol.27
, pp. 2224-2228
-
-
Reeves, J.H.1
Cumming, A.R.2
Gallagher, L.3
O'Brien, J.L.4
Santamaria, J.D.5
-
54
-
-
27744441283
-
In vitro and in vivo evaluation of enoxa-parin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes
-
10.1016/j.clinthera.2005.09.008 16291417
-
Isla A Gascón AR Maynar J Arzuaga A Corral E Martín A Solinís MA Muñoz JL In vitro and in vivo evaluation of enoxa-parin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes Clin Ther 2005, 27:1444-1451. 10.1016/j.clinthera.2005.09.008 16291417
-
(2005)
Clin Ther
, vol.27
, pp. 1444-1451
-
-
Isla, A.1
Gascón, A.R.2
Maynar, J.3
Arzuaga, A.4
Corral, E.5
Martín, A.6
Solinís, M.A.7
Muñoz, J.L.8
-
55
-
-
0036145979
-
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: On behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
-
11848446
-
Greaves M Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: On behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis Thromb Haemost 2002, 87:163-164. 11848446
-
(2002)
Thromb Haemost
, vol.87
, pp. 163-164
-
-
Greaves, M.1
-
56
-
-
4644242157
-
Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
10.1378/chest.126.3_suppl.311S 15383477
-
Warkentin TE Greinacher A Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126:311S-337S. 10.1378/ chest.126.3_suppl.311S 15383477
-
(2004)
Chest
, vol.126
-
-
Warkentin, T.E.1
Greinacher, A.2
-
58
-
-
0038689143
-
Frequency of heparin-induced thrombocytopenia in critical care patients
-
10.1592/phco.23.6.745.32188 12820817
-
Verma AK Levine M Shalansky SJ Carter CJ Kelton JG Frequency of heparin-induced thrombocytopenia in critical care patients Pharmacotherapy 2003, 23:745-753. 10.1592/phco.23.6.745.32188 12820817
-
(2003)
Pharmacotherapy
, vol.23
, pp. 745-753
-
-
Verma, A.K.1
Levine, M.2
Shalansky, S.J.3
Carter, C.J.4
Kelton, J.G.5
-
59
-
-
33947651116
-
Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill
-
17387236
-
Wester JP Leyte A Oudemans-van Straaten HM Bosman RJ van der Spoel JI Haak EA Porcelijn L Zandstra DF Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill Neth J Med 2007, 65:101-108. 17387236
-
(2007)
Neth J Med
, vol.65
, pp. 101-108
-
-
Wester, J.P.1
Leyte, A.2
Oudemans-van Straaten, H.M.3
Bosman, R.J.4
van der Spoel, J.I.5
Haak, E.A.6
Porcelijn, L.7
Zandstra, D.F.8
-
60
-
-
0035052894
-
Hirudin versus heparin for anticoagulation in continuous renal replacement therapy
-
10.1007/s001340100907 11403068
-
Vargas Hein O von Heymann C Lipps M Ziemer S Ronco C Neumayer HH Morgera S Welte M Kox WJ Spies C Hirudin versus heparin for anticoagulation in continuous renal replacement therapy Intensive Care Med 2001, 27:673-679. 10.1007/s001340100907 11403068
-
(2001)
Intensive Care Med
, vol.27
, pp. 673-679
-
-
Vargas Hein, O.1
von Heymann, C.2
Lipps, M.3
Ziemer, S.4
Ronco, C.5
Neumayer, H.H.6
Morgera, S.7
Welte, M.8
Kox, W.J.9
Spies, C.10
-
61
-
-
0027442550
-
Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172)
-
7509508
-
Magnani HN Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172) Thromb Haemost 1993, 70:554-561. 7509508
-
(1993)
Thromb Haemost
, vol.70
, pp. 554-561
-
-
Magnani, H.N.1
-
62
-
-
0041422394
-
Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
-
10.1345/aph.1D010 12921505
-
Dager WE White RH Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD Ann Pharmacother 2003, 37:1232-1236. 10.1345/aph.1D010 12921505
-
(2003)
Ann Pharmacother
, vol.37
, pp. 1232-1236
-
-
Dager, W.E.1
White, R.H.2
-
63
-
-
1542346478
-
Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction
-
10.1592/phco.24.4.409.33168 15040656
-
Williamson DR Boulanger I Tardif M Albert M Gregoire G Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction Pharmacotherapy 2004, 24:409-414. 10.1592/ phco.24.4.409.33168 15040656
-
(2004)
Pharmacotherapy
, vol.24
, pp. 409-414
-
-
Williamson, D.R.1
Boulanger, I.2
Tardif, M.3
Albert, M.4
Gregoire, G.5
-
64
-
-
12844249370
-
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia
-
10.1345/aph.1E480 15632219
-
Tang IY Cox DS Patel K Reddy BV Nahlik L Trevino S Murray PT Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia Ann Pharmacother 2005, 39:231-236. 10.1345/aph.1E480 15632219
-
(2005)
Ann Pharmacother
, vol.39
, pp. 231-236
-
-
Tang, I.Y.1
Cox, D.S.2
Patel, K.3
Reddy, B.V.4
Nahlik, L.5
Trevino, S.6
Murray, P.T.7
-
65
-
-
12444302398
-
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease
-
10.1111/j.1523-1755.2004.66022.x 15569338
-
Murray PT Reddy BV Grossman EJ Hammes MS Trevino S Ferrell J Tang I Hursting MJ Shamp TR Swan SK A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease Kidney Int 2004, 66:2446-2453. 10.1111/j.1523-1755.2004.66022.x 15569338
-
(2004)
Kidney Int
, vol.66
, pp. 2446-2453
-
-
Murray, P.T.1
Reddy, B.V.2
Grossman, E.J.3
Hammes, M.S.4
Trevino, S.5
Ferrell, J.6
Tang, I.7
Hursting, M.J.8
Shamp, T.R.9
Swan, S.K.10
-
66
-
-
0036266277
-
Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent
-
10.1007/s00134-002-1249-y 12029407
-
Fiaccadori E Maggiore U Rotelli C Minari M Melfa L Cappè G Cabassi A Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent Intensive Care Med 2002, 28:586-593. 10.1007/s00134-002-1249-y 12029407
-
(2002)
Intensive Care Med
, vol.28
, pp. 586-593
-
-
Fiaccadori, E.1
Maggiore, U.2
Rotelli, C.3
Minari, M.4
Melfa, L.5
Cappè, G.6
Cabassi, A.7
-
67
-
-
0028268061
-
Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure
-
8015647
-
Davenport A Will EJ Davison AM Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure Nephron 1994, 66:431-437. 8015647
-
(1994)
Nephron
, vol.66
, pp. 431-437
-
-
Davenport, A.1
Will, E.J.2
Davison, A.M.3
-
68
-
-
0031596158
-
Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration
-
10.1097/00003246-199807000-00021 9671370
-
Kozek-Langenecker SA Kettner SC Oismueller C Gonano C Speiser W Zimpfer M Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration Crit Care Med 1998, 26:1208-1212. 10.1097/00003246-199807000-00021 9671370
-
(1998)
Crit Care Med
, vol.26
, pp. 1208-1212
-
-
Kozek-Langenecker, S.A.1
Kettner, S.C.2
Oismueller, C.3
Gonano, C.4
Speiser, W.5
Zimpfer, M.6
-
69
-
-
0037083861
-
Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: A randomized controlled trial
-
12060975
-
Kozek-Langenecker SA Spiss CK Gamsjager T Domenig C Zimpfer M Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: A randomized controlled trial Wien Klin Wochenschr 2002, 114:96-101. 12060975
-
(2002)
Wien Klin Wochenschr
, vol.114
, pp. 96-101
-
-
Kozek-Langenecker, S.A.1
Spiss, C.K.2
Gamsjager, T.3
Domenig, C.4
Zimpfer, M.5
-
70
-
-
0037350428
-
Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration
-
10.1097/01.CCM.0000055374.77132.4D 12626998
-
Kozek-Langenecker SA Spiss CK Michalek-Sauberer A Felfernig M Zimpfer M Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration Crit Care Med 2003, 31:864-868. 10.1097/01.CCM.0000055374.77132.4D 12626998
-
(2003)
Crit Care Med
, vol.31
, pp. 864-868
-
-
Kozek-Langenecker, S.A.1
Spiss, C.K.2
Michalek-Sauberer, A.3
Felfernig, M.4
Zimpfer, M.5
-
71
-
-
33746608575
-
Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium
-
10.1515/CCLM.2006.164 16879061
-
Bakker AJ Boerma EC Keidel H Kingma P van der Voort PH Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium Clin Chem Lab Med 2006, 44:962-966. 10.1515/CCLM.2006.164 16879061
-
(2006)
Clin Chem Lab Med
, vol.44
, pp. 962-966
-
-
Bakker, A.J.1
Boerma, E.C.2
Keidel, H.3
Kingma, P.4
van der Voort, P.H.5
-
72
-
-
0036947439
-
Citrate clearance in children receiving continuous venovenous renal replacement therapy
-
10.1007/s00467-002-0963-6 12376810
-
Chadha V Garg U Warady BA Alon US Citrate clearance in children receiving continuous venovenous renal replacement therapy Pediatr Nephrol 2002, 17:819-824. 10.1007/s00467-002-0963-6 12376810
-
(2002)
Pediatr Nephrol
, vol.17
, pp. 819-824
-
-
Chadha, V.1
Garg, U.2
Warady, B.A.3
Alon, U.S.4
-
73
-
-
1242273866
-
Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation
-
14989634
-
Swartz R Pasko D O'Toole J Starmann B Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation Clin Nephrol 2004, 61:134-143. 14989634
-
(2004)
Clin Nephrol
, vol.61
, pp. 134-143
-
-
Swartz, R.1
Pasko, D.2
O'Toole, J.3
Starmann, B.4
-
74
-
-
0142025049
-
Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients
-
10.1097/01.CCM.0000084871.76568.E6 14530750
-
Kramer L Bauer E Joukhadar C Strobl W Gendo A Madl C Gangl A Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients Crit Care Med 2003, 31:2450-2455. 10.1097/ 01.CCM.0000084871.76568.E6 14530750
-
(2003)
Crit Care Med
, vol.31
, pp. 2450-2455
-
-
Kramer, L.1
Bauer, E.2
Joukhadar, C.3
Strobl, W.4
Gendo, A.5
Madl, C.6
Gangl, A.7
-
75
-
-
0035050839
-
Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation
-
10.1097/00003246-200104000-00010 11373461
-
Meier-Kriesche HU Gitomer J Finkel K DuBose T Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation Crit Care Med 2001, 29:748-752. 10.1097/ 00003246-200104000-00010 11373461
-
(2001)
Crit Care Med
, vol.29
, pp. 748-752
-
-
Meier-Kriesche, H.U.1
Gitomer, J.2
Finkel, K.3
DuBose, T.4
-
76
-
-
0025089550
-
Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
-
10.1038/ki.1990.300 2266683
-
Mehta RL McDonald BR Aguilar MM Ward DM Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients Kidney Int 1990, 38:976-981. 10.1038/ki.1990.300 2266683
-
(1990)
Kidney Int
, vol.38
, pp. 976-981
-
-
Mehta, R.L.1
McDonald, B.R.2
Aguilar, M.M.3
Ward, D.M.4
-
77
-
-
0000718113
-
Extracorporeal management of acute renal failure patients at high risk of bleeding
-
8320930
-
Ward DM Mehta RL Extracorporeal management of acute renal failure patients at high risk of bleeding Kidney Int Suppl 1993, 41:S237-S244. 8320930
-
(1993)
Kidney Int Suppl
, vol.41
-
-
Ward, D.M.1
Mehta, R.L.2
-
78
-
-
0034961879
-
Simplified citrate anticoagulation for continuous renal replacement therapy
-
10.1046/j.1523-1755.2001.00809.x 11422774
-
Tolwani AJ Campbell RC Schenk MB Allon M Warnock DG Simplified citrate anticoagulation for continuous renal replacement therapy Kidney Int 2001, 60:370-374. 10.1046/j.1523-1755.2001.00809.x 11422774
-
(2001)
Kidney Int
, vol.60
, pp. 370-374
-
-
Tolwani, A.J.1
Campbell, R.C.2
Schenk, M.B.3
Allon, M.4
Warnock, D.G.5
-
79
-
-
0038311022
-
A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions
-
10.1053/jcrc.2003.50006 12800123
-
Tobe SW Aujla P Walele AA Oliver MJ Naimark DM Perkins NJ Beardsall M A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions J Crit Care 2003, 18:121-129. 10.1053/ jcrc.2003.50006 12800123
-
(2003)
J Crit Care
, vol.18
, pp. 121-129
-
-
Tobe, S.W.1
Aujla, P.2
Walele, A.A.3
Oliver, M.J.4
Naimark, D.M.5
Perkins, N.J.6
Beardsall, M.7
-
80
-
-
0037322192
-
A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD)
-
12608553
-
Mitchell A Daul AE Beiderlinden M Schafers RF Heemann U Kribben A Peters J Philipp T Wenzel RR A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD) Clin Nephrol 2003, 59:106-114. 12608553
-
(2003)
Clin Nephrol
, vol.59
, pp. 106-114
-
-
Mitchell, A.1
Daul, A.E.2
Beiderlinden, M.3
Schafers, R.F.4
Heemann, U.5
Kribben, A.6
Peters, J.7
Philipp, T.8
Wenzel, R.R.9
-
81
-
-
4444243199
-
Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience
-
10.1159/000079171 15331942
-
Morgera S Scholle C Voss G Haase M Vargas-Hein O Krausch D Melzer C Rosseau S Zuckermann-Becker H Neumayer HH Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience Nephron Clin Pract 2004, 97:c131-c136. 10.1159/ 000079171 15331942
-
(2004)
Nephron Clin Pract
, vol.97
-
-
Morgera, S.1
Scholle, C.2
Voss, G.3
Haase, M.4
Vargas-Hein, O.5
Krausch, D.6
Melzer, C.7
Rosseau, S.8
Zuckermann-Becker, H.9
Neumayer, H.H.10
-
82
-
-
1342268344
-
Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study
-
10.1007/s00134-003-2047-x 14600809
-
Monchi M Berghmans D Ledoux D Canivet JL Dubois B Damas P Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study Intensive Care Med 2004, 30:260-265. 10.1007/s00134-003-2047-x 14600809
-
(2004)
Intensive Care Med
, vol.30
, pp. 260-265
-
-
Monchi, M.1
Berghmans, D.2
Ledoux, D.3
Canivet, J.L.4
Dubois, B.5
Damas, P.6
-
83
-
-
0032944876
-
Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
-
10.1046/j.1523-1755.1999.00444.x 10231464
-
Palsson R Niles JL Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding Kidney Int 1999, 55:1991-1997. 10.1046/j.1523-1755.1999.00444.x 10231464
-
(1999)
Kidney Int
, vol.55
, pp. 1991-1997
-
-
Palsson, R.1
Niles, J.L.2
-
84
-
-
0037083899
-
Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients
-
12060967
-
Thoenen M Schmid ER Binswanger U Schuepbach R Aerne D Schmidlin D Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients Wien Klin Wochenschr 2002, 114:108-114. 12060967
-
(2002)
Wien Klin Wochenschr
, vol.114
, pp. 108-114
-
-
Thoenen, M.1
Schmid, E.R.2
Binswanger, U.3
Schuepbach, R.4
Aerne, D.5
Schmidlin, D.6
-
85
-
-
0036022131
-
A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)
-
10.1081/JDI-120005366 12166699
-
Hofmann RM Maloney C Ward DM Becker BN A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF) Ren Fail 2002, 24:325-335. 10.1081/JDI-120005366 12166699
-
(2002)
Ren Fail
, vol.24
, pp. 325-335
-
-
Hofmann, R.M.1
Maloney, C.2
Ward, D.M.3
Becker, B.N.4
-
86
-
-
31644449094
-
A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration
-
16404696
-
Egi M Naka T Bellomo R Cole L French C Trethewy C Wan L Langenberg CC Fealy N Baldwin I A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration Int J Artif Organs 2005, 28:1211-1218. 16404696
-
(2005)
Int J Artif Organs
, vol.28
, pp. 1211-1218
-
-
Egi, M.1
Naka, T.2
Bellomo, R.3
Cole, L.4
French, C.5
Trethewy, C.6
Wan, L.7
Langenberg, C.C.8
Fealy, N.9
Baldwin, I.10
-
87
-
-
27544440480
-
Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting
-
16235478
-
Naka T Egi M Bellomo R Cole L French C Botha J Wan L Fealy N Baldwin I Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting Anaesth Intensive Care 2005, 33:601-608. 16235478
-
(2005)
Anaesth Intensive Care
, vol.33
, pp. 601-608
-
-
Naka, T.1
Egi, M.2
Bellomo, R.3
Cole, L.4
French, C.5
Botha, J.6
Wan, L.7
Fealy, N.8
Baldwin, I.9
-
88
-
-
27144486410
-
Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition
-
10.1053/j.ajkd.2005.08.010 16253732
-
Bihorac A Ross EA Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition Am J Kidney Dis 2005, 46:908-918. 10.1053/j.ajkd.2005.08.010 16253732
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 908-918
-
-
Bihorac, A.1
Ross, E.A.2
-
89
-
-
0036390012
-
Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge
-
10.1007/s00134-002-1443-y 12373466
-
Gabutti L Marone C Colucci G Duchini F Schonholzer C Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge Intensive Care Med 2002, 28:1419-1425. 10.1007/ s00134-002-1443-y 12373466
-
(2002)
Intensive Care Med
, vol.28
, pp. 1419-1425
-
-
Gabutti, L.1
Marone, C.2
Colucci, G.3
Duchini, F.4
Schonholzer, C.5
-
90
-
-
0042667173
-
A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration
-
10.1007/s00134-003-1801-4 12761615
-
Dorval M Madore F Courteau S Leblanc M A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration Intensive Care Med 2003, 29:1186-1189. 10.1007/s00134-003-1801-4 12761615
-
(2003)
Intensive Care Med
, vol.29
, pp. 1186-1189
-
-
Dorval, M.1
Madore, F.2
Courteau, S.3
Leblanc, M.4
-
91
-
-
0347286846
-
Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions
-
10.1093/ndt/gfg488 14671053
-
Cointault O Kamar N Bories P Lavayssiere L Angles O Rostaing L Genestal M Durand D Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions Nephrol Dial Transplant 2004, 19:171-178. 10.1093/ndt/gfg488 14671053
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 171-178
-
-
Cointault, O.1
Kamar, N.2
Bories, P.3
Lavayssiere, L.4
Angles, O.5
Rostaing, L.6
Genestal, M.7
Durand, D.8
-
92
-
-
0346728945
-
Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate
-
10.1053/j.ajkd.2003.09.014 14712429
-
Gupta M Wadhwa NK Bukovsky R Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate Am J Kidney Dis 2004, 43:67-73. 10.1053/j.ajkd.2003.09.014 14712429
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 67-73
-
-
Gupta, M.1
Wadhwa, N.K.2
Bukovsky, R.3
-
93
-
-
24044486511
-
Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system
-
10.1016/j.jcrc.2005.01.001 16139156
-
Bagshaw SM Laupland KB Boiteau PJ Godinez-Luna T Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system J Crit Care 2005, 20:155-161. 10.1016/ j.jcrc.2005.01.001 16139156
-
(2005)
J Crit Care
, vol.20
, pp. 155-161
-
-
Bagshaw, S.M.1
Laupland, K.B.2
Boiteau, P.J.3
Godinez-Luna, T.4
-
94
-
-
33746531773
-
Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: A comparison with nadroparin
-
16841283
-
Van der Voort PH Postma SR Kingma WP Boerma EC Van Roon EN Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: A comparison with nadroparin Int J Artif Organs 2006, 29:559-563. 16841283
-
(2006)
Int J Artif Organs
, vol.29
, pp. 559-563
-
-
Van der Voort, P.H.1
Postma, S.R.2
Kingma, W.P.3
Boerma, E.C.4
Van Roon, E.N.5
-
95
-
-
33748611903
-
Re: Regional citrate anticoagulation does not prolong filter survival during CVVH
-
10.1016/j.jcrc.2006.02.002 16990102
-
Spronk PE Steenbergen H ten Kleij M Rommes JH Re: Regional citrate anticoagulation does not prolong filter survival during CVVH J Crit Care 2006, 21:291-292. 10.1016/j.jcrc.2006.02.002 16990102
-
(2006)
J Crit Care
, vol.21
, pp. 291-292
-
-
Spronk, P.E.1
Steenbergen, H.2
ten Kleij, M.3
Rommes, J.H.4
-
96
-
-
16644392433
-
The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation
-
15593057
-
Gabutti L Ferrari N Mombelli G Keller F Marone C The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation J Nephrol 2004, 17:819-825. 15593057
-
(2004)
J Nephrol
, vol.17
, pp. 819-825
-
-
Gabutti, L.1
Ferrari, N.2
Mombelli, G.3
Keller, F.4
Marone, C.5
-
97
-
-
0030789993
-
Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis
-
10.1093/ndt/12.7.1387 9249774
-
Bos JC Grooteman MP van Houte AJ Schoorl M van Limbeek J Nubé MJ Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis Nephrol Dial Transplant 1997, 12:1387-1393. 10.1093/ndt/12.7.1387 9249774
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 1387-1393
-
-
Bos, J.C.1
Grooteman, M.P.2
van Houte, A.J.3
Schoorl, M.4
van Limbeek, J.5
Nubé, M.J.6
-
98
-
-
30344458809
-
Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis
-
10.1093/ndt/gfi069 16144857
-
Gritters M Grooteman MP Schoorl M Schoorl M Bartels PC Scheffer PG Teerlink T Schalkwijk CG Spreeuwenberg M Nubé MJ Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis Nephrol Dial Transplant 2006, 21:153-159. 10.1093/ndt/gfi069 16144857
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 153-159
-
-
Gritters, M.1
Grooteman, M.P.2
Schoorl, M.3
Schoorl, M.4
Bartels, P.C.5
Scheffer, P.G.6
Teerlink, T.7
Schalkwijk, C.G.8
Spreeuwenberg, M.9
Nubé, M.J.10
-
99
-
-
9344259685
-
Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation
-
10.1053/j.ajkd.2004.09.001 15558534
-
Wang PL Meyer MM Orloff SL Anderson S Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation Am J Kidney Dis 2004, 44:1110-1114. 10.1053/j.ajkd.2004.09.001 15558534
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 1110-1114
-
-
Wang, P.L.1
Meyer, M.M.2
Orloff, S.L.3
Anderson, S.4
|